ACET logo

Adicet Bio (ACET) EBITDA

Annual EBITDA

-$136.53 M
-$69.40 M-103.37%

December 31, 2023

Summary

Performance

1-Year Change

-103.37%

3-Year Change

-258.05%

5-Year Change

-1475.53%

15-Year Change

-340.02%

ACET EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.11%
ACET annual EBITDA is higher than 13.11% of companies in Healthcare sector

High & Low

All-time High

$73.55 M
ACET annual EBITDA is currently -285.64% below its historical high of $73.55 million

3-Year Low

-$136.53 M
ACET annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ACET previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 19, 2025
ACET next annual earnings announcement is scheduled for Mar 19, 2025

OtherACETprofitabilitymetrics:

Annual Revenue

-
ACET annual revenue value is unknown

Annual Net Income

-$142.66 M
ACET annual net profit is -$142.66 million

Annual EBIT

-$142.63 M
ACET annual earnings before interest & taxes is -$142.63 million

Annual EPS

-$3.31
ACET annual earnings per share is -$3.31

Quarterly EBITDA

-$28.89 M
-$586.00 K-2.07%

September 30, 2024

Summary

Performance

3-Month Change

-2.07%

1-Year Change

+40.12%

3-Year Change

+40.12%

5-Year Change

+40.12%

ACET Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.02%
ACET quarterly EBITDA is higher than 16.02% of companies in Healthcare sector

High & Low

All-time High

$4.99 M
ACET quarterly EBITDA is currently -679.09% below its historical high of $4.99 million

3-Year Low

-$48.24 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACET previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
ACET next earnings announcement is scheduled for Mar 19, 2025

OtherACETprofitabilitymetrics:

Quarterly Revenue

-
ACET quarterly revenue value is unknown

Quarterly Net Income

-$30.48 M
ACET quarterly net profit is -$30.48 million

Quarterly EBIT

-$30.48 M
ACET quarterly earnings before interest & taxes is -$30.48 million

Quarterly EPS

-$0.34
ACET quarterly earnings per share is -$0.34

TTM EBITDA

-$111.35 M
+$19.35 M+14.81%

September 30, 2024

Summary

Performance

3-Month Change

+14.81%

1-Year Change

+19.04%

3-Year Change

+19.04%

5-Year Change

+19.04%

ACET TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.85%
ACET TTM EBITDA is higher than 15.85% of companies in Healthcare sector

High & Low

All-time High

-$14.78 M

3-Year Low

-$137.53 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACET previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
ACET next earnings announcement is scheduled for Mar 19, 2025

OtherACETprofitabilitymetrics:

TTM Revenue

-
ACET TTM revenue value is unknown

TTM Net Income

-$117.88 M
ACET TTM net profit is -$117.88 million

TTM EBIT

-$117.88 M
ACET TTM earnings before interest & taxes is -$117.88 million

TTM EPS

-$1.70
ACET TTM earnings per share is -$1.70

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$136.53 M
ACET annual EBITDA is -$136.53 million

Annual Net Income

-$142.66 M
ACET annual net profit is -$142.66 million

Annual Interest Expense

$25.00 K
ACET annual interest expense is $25.00 thousand

Annual Income Tax

$0.00
ACET annual income tax is $0.00

Annual D&A

$6.10 M
ACET annual depreciation & amortization is $6.10 million

ACET EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-103.4%+40.1%+19.0%
3 y3 years-258.1%+40.1%+19.0%
5 y5 years-1475.5%+40.1%+19.0%

ACET EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-126.0%at low-679.1%+40.1%-223.4%+19.0%
5 y5-year-407.9%at low-679.1%+40.1%-428.7%+19.0%
alltimeall time-285.6%+42.9%-679.1%+40.1%-653.5%+19.0%

Adicet Bio EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$28.89 M(+2.1%)
-$111.35 M(-14.8%)
Jun 2024
-
-$28.30 M(+7.3%)
-$130.70 M(-1.9%)
Mar 2024
-
-$26.36 M(-5.2%)
-$133.29 M(-2.4%)
Dec 2023
-$136.53 M(+103.4%)
-$27.80 M(-42.4%)
-$136.54 M(-0.7%)
Sep 2023
-
-$48.24 M(+56.2%)
-$137.53 M(+24.5%)
Jun 2023
-
-$30.89 M(+4.3%)
-$110.51 M(+8.6%)
Mar 2023
-
-$29.61 M(+2.8%)
-$101.73 M(+51.5%)
Dec 2022
-$67.14 M(+11.1%)
-$28.79 M(+35.7%)
-$67.14 M(+24.8%)
Sep 2022
-
-$21.22 M(-4.1%)
-$53.78 M(+16.6%)
Jun 2022
-
-$22.11 M(-543.4%)
-$46.13 M(+34.0%)
Mar 2022
-
$4.99 M(-132.3%)
-$34.43 M(-43.0%)
Dec 2021
-$60.41 M(+58.4%)
-$15.43 M(+13.8%)
-$60.41 M(+12.5%)
Sep 2021
-
-$13.56 M(+30.2%)
-$53.71 M(-1.6%)
Jun 2021
-
-$10.42 M(-50.4%)
-$54.59 M(+4.4%)
Mar 2021
-
-$20.99 M(+140.4%)
-$52.27 M(+37.1%)
Dec 2020
-$38.13 M(+41.9%)
-$8.73 M(-39.5%)
-$38.13 M(+6.9%)
Sep 2020
-
-$14.44 M(+78.1%)
-$35.69 M(-0.9%)
Jun 2020
-
-$8.11 M(+18.3%)
-$36.02 M(+29.0%)
Mar 2020
-
-$6.85 M(+9.0%)
-$27.91 M(+32.5%)
Dec 2019
-$26.88 M(+210.2%)
-$6.28 M(-57.5%)
-$21.06 M(+42.5%)
Sep 2019
-
-$14.78 M
-$14.78 M
Dec 2018
-$8.67 M(-96.4%)
-
-
Jun 2018
-$239.16 M(-520.4%)
-
-
Jun 2017
$56.88 M(-22.7%)
-
-
Jun 2016
$73.55 M(+12.0%)
-
-
Jun 2015
$65.66 M(+19.7%)
-
-
Jun 2014
$54.87 M(+25.8%)
-
-
Jun 2013
$43.62 M(+27.1%)
-
-
DateAnnualQuarterlyTTM
Jun 2012
$34.31 M(+42.8%)
-
-
Jun 2011
$24.03 M(+81.7%)
-
-
Jun 2010
$13.23 M(-10.0%)
-
-
Jun 2009
$14.70 M(-40.5%)
-
-
Jun 2008
$24.71 M(+46.6%)
-
-
Jun 2007
$16.86 M(+20.5%)
-
-
Jun 2006
$13.99 M(+8.6%)
-
-
Jun 2005
$12.88 M(-25.3%)
-
-
Jun 2004
$17.24 M(+22.6%)
-
-
Jun 2003
$14.06 M(+56.9%)
-
-
Jun 2002
$8.96 M(+32.5%)
-
-
Jun 2001
$6.76 M(-30.6%)
-
-
Jun 2000
$9.75 M(+25.0%)
-
-
Jun 1999
$7.80 M(-20.4%)
-
-
Jun 1998
$9.80 M(+19.5%)
-
-
Jun 1997
$8.20 M(-23.4%)
-
-
Jun 1996
$10.70 M(-5.3%)
-
-
Jun 1995
$11.30 M(+4.6%)
-
-
Jun 1994
$10.80 M(+272.4%)
-
-
Jun 1993
$2.90 M(-67.0%)
-
-
Jun 1992
$8.80 M(+15.8%)
-
-
Jun 1991
$7.60 M(+4.1%)
-
-
Jun 1990
$7.30 M(0.0%)
-
-
Jun 1989
$7.30 M(+1.4%)
-
-
Jun 1988
$7.20 M(+10.8%)
-
-
Jun 1987
$6.50 M(-27.0%)
-
-
Jun 1986
$8.90 M(+1.1%)
-
-
Jun 1985
$8.80 M(+1.1%)
-
-
Jun 1984
$8.70 M
-
-

FAQ

  • What is Adicet Bio annual EBITDA?
  • What is the all time high annual EBITDA for Adicet Bio?
  • What is Adicet Bio annual EBITDA year-on-year change?
  • What is Adicet Bio quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Adicet Bio?
  • What is Adicet Bio quarterly EBITDA year-on-year change?
  • What is Adicet Bio TTM EBITDA?
  • What is the all time high TTM EBITDA for Adicet Bio?
  • What is Adicet Bio TTM EBITDA year-on-year change?

What is Adicet Bio annual EBITDA?

The current annual EBITDA of ACET is -$136.53 M

What is the all time high annual EBITDA for Adicet Bio?

Adicet Bio all-time high annual EBITDA is $73.55 M

What is Adicet Bio annual EBITDA year-on-year change?

Over the past year, ACET annual EBITDA has changed by -$69.40 M (-103.37%)

What is Adicet Bio quarterly EBITDA?

The current quarterly EBITDA of ACET is -$28.89 M

What is the all time high quarterly EBITDA for Adicet Bio?

Adicet Bio all-time high quarterly EBITDA is $4.99 M

What is Adicet Bio quarterly EBITDA year-on-year change?

Over the past year, ACET quarterly EBITDA has changed by +$19.35 M (+40.12%)

What is Adicet Bio TTM EBITDA?

The current TTM EBITDA of ACET is -$111.35 M

What is the all time high TTM EBITDA for Adicet Bio?

Adicet Bio all-time high TTM EBITDA is -$14.78 M

What is Adicet Bio TTM EBITDA year-on-year change?

Over the past year, ACET TTM EBITDA has changed by +$26.18 M (+19.04%)